NAV
$47.05
AUM
$500.3M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.94
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +6.57% | +1.94% | +5.35% | +16.07% | +14.33% | +6.01% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 3.29% |
| 2 | HSBA.L | HSBC Holdings PLC | 1.83% |
| 3 | 9984.T | SoftBank Group Corp | 1.61% |
| 4 | SHEL.L | Shell PLC | 1.56% |
| 5 | NOVN.SW | Novartis AG Registered Shares | 1.55% |
| 6 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.43% |
| 7 | NESN.SW | Nestle SA | 1.36% |
| 8 | 8306.T | Mitsubishi UFJ Financial Group Inc | 1.31% |
| 9 | SIE.DE | Siemens AG | 1.17% |
| 10 | AZN.L | AstraZeneca PLC | 1.17% |
The fund invests in a representative basket of developed market equity securities, excluding the United States and Canada, generally weighted by market capitalization. It invests approximately 90% of its assets in the above-referenced equity securities. The remainder of the net assets, which WisdomTree Asset Management, Inc., the fund’s investment adviser expects to be in cash and cash equivalents, will serve as collateral for U.S. Treasury futures contracts positions of varying maturities ranging from 2 to 30 years, which are selected to achieve a target duration of 3 to 8 years. It is non-diversified.
Inception Date: 2021-05-18